Common use of Licensor Development Obligations Clause in Contracts

Licensor Development Obligations. 12.5.1. Licensor shall use all reasonable commercial efforts to complete the clinical development of the Technology outside of the Territory pursuant to the Licensor Clinical Development Plan. Any expenses incurred over and above the Maximum Incostop Amount, as adjusted pursuant to this Clause 12 (for the development and commercialization of Incostop) and the Maximum Anoheal Amount (for the development and commercialization of Anoheal) to complete the Licensor Clinical Development Plan shall be borne solely by the Licensor, with the provision that any development work not provided for in the Clinical Development Plan which is performed by the Licensor at Licensee's request shall be paid by Licensee in addition to the Maximum Anoheal Amount or the Maxim Incostop Amount (as applicable).